相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Assessment of Systemic Delivery of rAAVrh74.MHCK7.micro-dystrophin in Children With Duchenne Muscular Dystrophy A Nonrandomized Controlled Trial
Jerry R. Mendell et al.
JAMA NEUROLOGY (2020)
Gene Delivery for Limb-Girdle Muscular Dystrophy Type 2D by Isolated Limb Infusion
Jerry R. Mendell et al.
HUMAN GENE THERAPY (2019)
Prevalence, pathological mechanisms, and genetic basis of limb-girdle muscular dystrophies: A review
Eskandar Taghizadeh et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Systemic Delivery of Dysferlin Overlap Vectors Provides Long-Term Gene Expression and Functional Improvement for Dysferlinopathy
Rachael A. Potter et al.
HUMAN GENE THERAPY (2018)
UNTANGLING THE COMPLEXITY OF LIMB-GIRDLE MUSCULAR DYSTROPHIES
Teerin Liewluck et al.
MUSCLE & NERVE (2018)
The Limb-Girdle Muscular Dystrophies: Is Treatment on the Horizon?
Mary Lynn Chu et al.
NEUROTHERAPEUTICS (2018)
Systemic MV-Mediated β-Sarcoglycan Delivery Targeting Cardiac and Skeletal Muscle Ameliorates Histological and Functional Deficits in LGMD2E Mice
Eric R. Pozsgai et al.
MOLECULAR THERAPY (2017)
β-Sarcoglycan gene transfer decreases fibrosis and restores force in LGMD2E mice
E. R. Pozsgai et al.
GENE THERAPY (2016)
Limb girdle muscular dystrophies: classification, clinical spectrum and emerging therapies
John Vissing
CURRENT OPINION IN NEUROLOGY (2016)
Pharmacodynamics of anti-HIV gene therapy using viral vectors and targeted endonucleases
Pavitra Roychoudhury et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
AAV.Dysferlin Overlap Vectors Restore Function in Dysferlinopathy Animal Models
Patricia C. Sondergaard et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2015)
Vascular Delivery of rAAVrh74.MCK.GALGT2 to the Gastrocnemius Muscle of the Rhesus Macaque Stimulates the Expression of Dystrophin and Laminin α2 Surrogates
Louis G. Chicoine et al.
MOLECULAR THERAPY (2014)
Plasmapheresis Eliminates the Negative Impact of AAV Antibodies on Microdystrophin Gene Expression Following Vascular Delivery
L. G. Chicoine et al.
MOLECULAR THERAPY (2014)
mdx5cv Mice Manifest More Severe Muscle Dysfunction and Diaphragm Force Deficits than Do mdx Mice
Nicholas Beastrom et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Early Treatment With Lisinopril and Spironolactone Preserves Cardiac and Skeletal Muscle in Duchenne Muscular Dystrophy Mice
Jill A. Rafael-Fortney et al.
CIRCULATION (2011)
Sustained Alpha-Sarcoglycan Gene Expression after Gene Transfer in Limb-Girdle Muscular Dystrophy, Type 2D
Jerry R. Mendell et al.
ANNALS OF NEUROLOGY (2010)
Persistent Expression of FLAG-tagged Micro-dystrophin in Nonhuman Primates Following Intramuscular and Vascular Delivery
Louise R. Rodino-Klapac et al.
MOLECULAR THERAPY (2010)
Limb-Girdle Muscular Dystrophy Type 2D Gene Therapy Restores α-Sarcoglycan and Associated Proteins
Jerry R. Mendell et al.
ANNALS OF NEUROLOGY (2009)
Construction and analysis of compact muscle-specific promoters for AAV vectors
B. Wang et al.
GENE THERAPY (2008)
Sarcolemma-localized nNOS is required to maintain activity after mild exercise
Yvonne M. Kobayashi et al.
NATURE (2008)
Lack of toxicity of alpha-sarcoglycan overexpression supports clinical gene transfer trial in LGMD2D
L. R. Rodino-Klapac et al.
NEUROLOGY (2008)
A translational approach for limb vascular delivery of the micro-dystrophin gene without high volume or high pressure for treatment of Duchenne muscular dystrophy
Louise R. Rodino-Klapac et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2007)
Characterization of adeno-associated virus genomes isolated from human tissues
BC Schnepp et al.
JOURNAL OF VIROLOGY (2005)
Adeno-associated virus terminal repeat (TR) mutant generates self-complementary vectors to overcome the rate-limiting step to transduction in vivo
DM McCarty et al.
GENE THERAPY (2003)
Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesis
DM McCarty et al.
GENE THERAPY (2001)
分享论文
